Viking Global Investors makes bold bets in finance sector with top holdings in US Bancorp, Visa, and Progressive Corp.
Fasudil is under clinical development by Woolsey Pharmaceuticals and currently in Phase II for Progressive Supranuclear Palsy .
Tolebrutinib is under clinical development by Sanofi and currently in Phase III for Secondary Progressive Multiple Sclerosis (SPMS).
As the holidays come to a close, Progressive narrowly reclaimed the top spot on Media Monitors’ Radio Spot Ten for the week ...